WEST DES MOINES, Iowa, Sept. 25 /CNW/ -- Newsham Genetics, LC announced
today that it has entered into a definitive purchase agreement to acquire
Monsanto Choice Genetics, Inc. The transaction will be completed as soon as
practical. Terms of the agreement were not disclosed.
The acquisition of Monsanto Choice Genetics, Inc. (MCG) will further
strengthen Newsham's expanding base of business, according to Newsham Genetics
Co-CEO Brent Mitchell. "Additionally, we'll be able to add new products and
lines that complement our current offerings, accessing new genetic
combinations that provide the most value to our customers, providing even more
"With Monsanto Choice Genetics and Newsham Genetics currently the second
and third largest swine genetics companies, the acquisition will create a very
strong and vibrant player in the North American market with the most extensive
technology in the industry," says Mitchell.
"We have great respect for the entire Monsanto Choice Genetics team of
professionals and are excited about our future together," explains Newsham's
Co-CEO Mark Weaver, DVM.
Newsham Genetics placed high value on the significant investment made by
MCG over the past 10 years in their genomics platform. According to Weaver,
"Monsanto developed the most extensive swine genomic map in the industry, with
over 6,000 genomic marker associations for swine performance. This technology
will allow Newsham to accelerate genetic progress across many different traits
for the industry."
As part of the agreement, a three-year research alliance has been
established between the two companies. The alliance will focus on technology
and the genomics platform to maximize the value created in the industry from
"We're pleased Newsham Genetics is acquiring this business and will
continue to advance the genomic and marker technology platform for the swine
industry," says Kevin Holloway, President of Monsanto's Animal Agriculture
unit. "The research alliance illustrates Newsham is committed to continuing
genomic research and harvesting the rich pipeline that MCG has developed."
About Newsham Genetics
The largest privately owned swine genetics company in the U.S., Newsham
Genetics delivers superior performance breeding solutions through its
SuperMom(TM) female and SuperSire(TM) Terminal Boar lines. Using its unique
Gentel(R) selection technology, Newsham is a customer-focused provider of high
performance, high health swine genetics. Learn more at http://www.newsham.com.
Monsanto Choice Genetics, Inc. is a wholly owned subsidiary of DEKALB
Genetics Corporation, which is a wholly owned subsidiary of Monsanto Company.
Monsanto (NYSE: MON) is a leading global provider of technology-based
solutions and agricultural products that improve farm productivity and food
quality. Learn more at http://www.monsanto.com.
For further information:
For further information: Jim Schirmer of Newsham Genetics,
+1-515-225-9420, ext. 2216, email@example.com; or Danielle Jany of
Monsanto +1-314-694-2478, firstname.lastname@example.org Web Site: